ACCORD (2008) — Trial Summary
ACCORD (2008): Randomized trial in adults with type 2 diabetes at high cardiovascular risk comparing intensive glucose control (target HbA1c <6%) versus standard glucose control (target HbA1c 7.0–7.9%), with additional blood-pressure and lipid factorial arms (NCT00000620). Primary outcome: nonfatal
References
- Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545-2559.